Recombinant Tas2r106 is produced using multiple expression systems for biochemical and immunological studies:
Production protocols emphasize endotoxin levels <1.0 EU/μg and stability across storage conditions (-80°C for long-term) .
Tas2r106 is expressed in mouse vallate papillae taste cells, though at lower levels compared to other Tas2rs like Tas2r118 .
Unlike human TAS2Rs, mouse Tas2r106 shows distinct agonist selectivity, responding to bitter compounds critical for murine ecological niches .
Neutrophils express Tas2r106 alongside Tas2r126/143, where it enhances CXCL2-stimulated migration via ROCK-dependent phosphorylation of myosin light chain 2 (MLC2) .
Knockout studies in Tas2r126/135/143−/− mice confirm abolished neutrophil migration responses to bitter agonists like arbutin .
Recombinant Tas2r106 is utilized in:
Ligand Screening: Identifying bitter compounds via calcium flux assays in heterologous cell systems .
Immune Studies: Investigating neutrophil chemotaxis mechanisms using in vitro migration assays .
Structural Biology: Mapping transmembrane domain interactions using tagged protein variants .
Mouse Tas2r106 exhibits functional divergence from human orthologs:
Current limitations include incomplete agonist profiling and lack of high-resolution structural data. Advances in cryo-EM and organoid models could elucidate Tas2r106’s role in taste-immune crosstalk .
Tas2r106 belongs to the Tas2r family of G protein-coupled receptors that mediate bitter taste perception in mice. These receptors are expressed in taste receptor cells located primarily in the posterior papillae of the mouse tongue. Mouse Tas2r genes vary in their expression levels, with some being highly abundant (like Tas2r108, Tas2r118, Tas2r126, Tas2r135, and Tas2r137) while others are expressed at lower levels . Tas2r106 is one of approximately 35 putatively functional bitter taste receptors in mice that collectively enable recognition of diverse bitter compounds .
Tas2r106 expression can be detected using quantitative RT-PCR (qRT-PCR) and in situ hybridization techniques. For qRT-PCR, RNA should be isolated from posterior tongue epithelium, converted to cDNA, and amplified using Tas2r106-specific primers. Results are typically normalized to housekeeping genes or to α-gustducin levels as demonstrated in studies of other Tas2r genes . For in situ hybridization, tongue tissue sections (particularly vallate papillae) should be processed with Tas2r106-specific probes, with appropriate sense probes as negative controls. Visualization can be accomplished through standard colorimetric or fluorescence methods, with signal intensity variations observed among different Tas2r genes reflecting their relative expression levels .
While the search results don't specifically mention Tas2r106 expression patterns, studies of the mouse Tas2r family show significant variation in expression levels. Some receptors like Tas2r118 are detected in many taste cells with strong signal intensity, while others like Tas2r120 or Tas2r102 are rarely expressed with faint staining . The expression pattern of Tas2r106 would need to be determined through specific qRT-PCR analysis and in situ hybridization studies. Data from related Tas2r genes suggests it may have a distinct expression profile that contributes to the heterogeneous bitter taste receptor cell population in mouse gustatory tissue .
For functional characterization of Tas2r106, heterologous expression systems using HEK293T cells represent the gold standard. The most sensitive approach involves cells stably expressing the chimeric G protein Gα16gust44, which couples bitter taste receptors to calcium signaling pathways. This system has proven more sensitive than Gα15-based assays for detecting responses of other mouse Tas2r receptors . Transfection of Tas2r106 expression constructs into these cells, followed by calcium imaging assays using fluorescent calcium indicators (e.g., Fluo-4), allows for quantitative measurement of receptor activation in response to potential agonists. This approach enables determination of both efficacy (maximum response amplitude) and potency (EC50 values) of various compounds .
A comprehensive calcium imaging assay for Tas2r106 should follow these methodological steps:
Cell preparation: Transfect HEK293T cells stably expressing Gα16gust44 with Tas2r106 expression constructs.
Plate cells in imaging-compatible formats (96-well plates or coverslips) 24-48 hours prior to assay.
Load cells with calcium-sensitive dye (e.g., Fluo-4 AM) for 1 hour.
Establish baseline fluorescence before compound addition.
Prepare test compounds at multiple concentrations (typically 1-300 μM) in assay buffer.
Add compounds and monitor changes in fluorescence intensity.
Quantify responses as relative fluorescence change (ΔF/F).
Include positive controls (known bitter compounds) and negative controls (buffer alone).
Generate concentration-response curves to determine threshold concentrations and EC50 values.
This methodological approach has successfully identified agonists for multiple mouse Tas2r receptors and can be applied to characterize Tas2r106 activation profiles .
When designing experiments to characterize Tas2r106 specificity, researchers should consider:
Compound selection: Test a diverse panel of bitter compounds (>100 compounds) from different structural classes to determine receptor tuning breadth.
Concentration range: Evaluate compounds across a wide concentration range (typically 0.1-1000 μM) to establish both threshold concentrations and EC50 values.
Experimental controls: Include known bitter taste receptor agonists as positive controls and empty vector-transfected cells as negative controls.
Receptor specificity: Test the same compound panel across multiple Tas2r receptors to identify Tas2r106-specific agonists versus shared agonists.
Statistical approach: Use appropriate statistical methods for concentration-response analysis, such as nonlinear regression with variable slope parameters.
Experimental design: Implement within-subjects design (testing all compounds on the same batch of transfected cells) to minimize variability .
These considerations ensure robust characterization of Tas2r106 specificity profiles while minimizing experimental artifacts.
Mouse bitter taste receptors demonstrate considerable variation in their tuning breadth, ranging from specialists that recognize few compounds to generalists that respond to many bitter substances. For example, Tas2r105 functions as a generalist receptor responding to >30% of tested bitter compounds, while other Tas2r receptors have narrower response profiles .
To determine Tas2r106's tuning breadth, researchers should:
Systematically test Tas2r106 against a comprehensive bitter compound library (>100 compounds)
Compare response profiles with other characterized mouse Tas2r receptors
Calculate the percentage of active compounds from the test library
Classify Tas2r106 as specialist, intermediate, or generalist based on its activation profile
Functional orthology between Tas2r106 and related receptors in other species should also be evaluated to understand evolutionary relationships and potential specialized roles in detecting compounds of species-specific relevance .
To establish correlations between Tas2r106 activation in vitro and behavioral responses in mice, researchers should implement a multi-level experimental approach:
In vitro characterization:
Identify specific Tas2r106 agonists through heterologous expression systems
Determine potency (EC50) and efficacy (maximum response) parameters
Identify Tas2r106-specific compounds not activating other Tas2r receptors
Behavioral testing:
Conduct brief-access taste tests using compounds identified as Tas2r106 agonists
Implement two-bottle preference tests at multiple concentrations
Compare wild-type mice with Tas2r106 knockout models
Data analysis:
This comprehensive approach allows researchers to determine whether Tas2r106 activation is necessary and/or sufficient for behavioral aversion to specific bitter compounds.
Identifying endogenous agonists for Tas2r106 requires a strategic research approach:
Bioinformatic screening:
Analyze structural similarities between known Tas2r agonists
Use computational modeling to predict binding of endogenous molecules
Screen databases of endogenous metabolites for structural compatibility
Biological sample testing:
Prepare extracts from relevant tissues (tongue, gastrointestinal tract)
Fractionate extracts using HPLC or other separation techniques
Test fractions for Tas2r106 activation in heterologous expression systems
Identify active components through mass spectrometry
Validation studies:
Studies of other Tas2r receptors have identified physiologically relevant compounds such as bacterial quorum-sensing molecules (N-acyl homoserine lactones) that specifically activate certain receptors (e.g., Tas2r105), suggesting similar approaches may reveal endogenous agonists for Tas2r106 .
Generating Tas2r106 genetic models requires careful consideration of taste receptor biology:
CRISPR/Cas9 genome editing:
Design guide RNAs targeting unique regions of Tas2r106
Introduce early stop codons or frameshift mutations to disrupt function
Verify knockout through sequencing and expression analysis
Consider potential compensation by other Tas2r genes
Reporter gene knock-in strategies:
Replace Tas2r106 coding sequence with fluorescent reporters (GFP, mCherry)
Use self-cleaving peptides (T2A) to maintain Tas2r106 expression while enabling visualization
Implement Cre-recombinase systems for conditional expression
Validation approaches:
These genetic models are essential tools for investigating Tas2r106's specific role within the broader bitter taste reception system.
Structure-function analysis of Tas2r106 requires systematic molecular approaches:
Comparative sequence analysis:
Align Tas2r106 with functionally characterized Tas2r receptors
Identify conserved and divergent regions that may influence ligand specificity
Compare with human TAS2R orthologs with known structure-function relationships
Site-directed mutagenesis:
Target predicted ligand-binding domains or G-protein coupling regions
Create point mutations at conserved residues in transmembrane domains
Develop chimeric receptors between Tas2r106 and receptors with different agonist profiles
Functional characterization:
This systematic approach can reveal critical residues for agonist recognition and provide insights into the molecular determinants of Tas2r106 function.
When designing a full factorial experiment to investigate Tas2r106, researchers should consider:
Factor selection:
Independent variables: compound type, concentration, receptor variant
Dependent variables: calcium response amplitude, EC50 values, activation kinetics
Experimental conditions:
Between-subjects vs. within-subjects design
Number of experimental conditions (design cells)
Sample size per condition
Statistical power considerations:
For example, a 3×2 full factorial design might investigate three agonist concentrations and two receptor variants (wild-type vs. mutant), resulting in six experimental conditions. Sample size should be determined based on expected effect sizes and desired statistical power .
Determining appropriate sample size for Tas2r106 functional studies involves several methodological considerations:
Statistical power calculation:
Estimate effect size based on preliminary data or literature
Set desired statistical power (typically 0.8 or higher)
Determine type I error rate (typically α = 0.05)
Calculate minimum sample size using power analysis software
Study design factors:
Between-subjects design requires more samples than within-subjects design
Consider variability in transfection efficiency and receptor expression
Account for technical replicates vs. biological replicates
Practical approach:
Proper sample size estimation ensures reliable detection of biologically meaningful effects while optimizing resource utilization.
Analyzing Tas2r106 activation data requires tailored statistical approaches:
Concentration-response analysis:
Nonlinear regression using four-parameter logistic model
Determination of EC50 values with 95% confidence intervals
Comparison of curve parameters across experiments or conditions
Statistical tests for differences in potency or efficacy
Compound comparison:
ANOVA with post-hoc tests for multiple compound comparisons
Hierarchical clustering of compounds based on activation profiles
Principal component analysis to identify response patterns
Data presentation:
These approaches enable rigorous comparison of Tas2r106 responses to various compounds and conditions.
Distinguishing specific from non-specific responses in Tas2r106 functional assays requires careful experimental controls and analytical approaches:
Essential controls:
Empty vector-transfected cells to identify receptor-independent responses
Mock-transfected cells to control for transfection reagent effects
Vehicle controls to account for solvent effects
Positive controls with known bitter receptor agonists
Analytical methods:
Statistical comparison between test and control responses
Signal-to-background ratio calculation
Concentration-dependence analysis (specific responses typically show dose-dependence)
Response kinetics analysis (specific responses often have distinct temporal profiles)
Validation approaches:
These methodological approaches minimize false positives and ensure identification of genuine Tas2r106 agonists.
Incorporating Tas2r106 into systems-level analyses of taste receptor signaling requires integrative approaches:
Co-expression studies:
Analyze co-expression patterns with other Tas2r receptors in single taste cells
Investigate co-expression with signaling components (α-gustducin, PLCβ2, TRPM5)
Implement single-cell RNA sequencing to identify Tas2r106-expressing cell populations
Signaling pathway analysis:
Investigate G-protein coupling specificity of Tas2r106
Compare downstream calcium signaling kinetics with other Tas2r receptors
Examine potential cross-talk with other taste modalities
Network modeling approaches:
These approaches position Tas2r106 studies within the broader context of taste perception and signaling networks.
Investigating Tas2r106 expression in non-gustatory tissues requires specialized techniques:
Sensitive detection methods:
Digital droplet PCR for absolute quantification of low-abundance transcripts
RNA-seq with sufficient depth to detect low-expression genes
Nested PCR approaches for increased sensitivity
Tissue preparation considerations:
Careful dissection and separation of target tissues
Enrichment of specific cell populations through FACS or other methods
Preservation techniques to maintain RNA integrity
Comparative analysis:
Studies have demonstrated Tas2r expression in various non-gustatory tissues such as testis and heart, with expression patterns differing from those observed in taste papillae . Similar approaches can reveal potential extra-oral functions of Tas2r106.